Tanboga, I. H. Et Al. 2016. The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients. CLINICAL CARDIOLOGY , vol.39, no.10 , 615-620.

Tanboga, I. H., Topcu, S., Aksakal, E., Gulcu, O., Aksakal, E., Aksu, U., ... Oduncu, V.(2016). The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients. CLINICAL CARDIOLOGY , vol.39, no.10, 615-620.

Tanboga, İbrahim Et Al. "The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients," CLINICAL CARDIOLOGY , vol.39, no.10, 615-620, 2016

Tanboga, İbrahim H. Et Al. "The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients." CLINICAL CARDIOLOGY , vol.39, no.10, pp.615-620, 2016

Tanboga, I. H. Et Al. (2016) . "The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients." CLINICAL CARDIOLOGY , vol.39, no.10, pp.615-620.

@article{article, author={İbrahim Halil TANBOĞA Et Al. }, title={The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients}, journal={CLINICAL CARDIOLOGY}, year=2016, pages={615-620} }